Liabilities / Assets
71st percentile
Higher debt load relative to assets than 71% of similar nonprofits.
Oregon Biotechnology Associati
990 • Fiscal year 2019 • EIN 93-1009329
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.23x
Liabilities / Revenue
62nd percentile
Higher debt load relative to revenue than 62% of similar nonprofits.
Net Margin
14th percentile
Higher net margin than 14% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
37th percentile
Faster asset growth than 37% of similar nonprofits.
Revenue Growth
90th percentile
Faster revenue growth than 90% of similar nonprofits.
Balance Sheet
Assets
Up$353,850
Up $2,472 (+0.7%) from 2018
Net Assets
Down$271,844
Down $58,963 (-18%) from 2018
Liabilities
Up$82,006
Up $61,435 (+299%) from 2018
Revenue And Expenses
Revenue
Up$701,485
Up $170,182 (+32%) from 2018
Expenses
Up$766,513
Up $135,369 (+21%) from 2018
Net Income
Up-$65,028
Up $34,813 (+35%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2019 to Dec 31, 2019
Mission and Program Overview
Mission
Promote growth and quality of the Bioscience Industry in Oregon through community collaboration and commercialzation
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $353,850
- Liabilities
- $82,006
- Net assets
- $271,844
- Revenue
- $701,485
- Expenses
- $766,513
- Net income
- -$65,028